Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05697185
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-01-25
First Post:
2023-01-15
Brief Title:
Safety and Efficacy of Evolocumab in Ischemic Stroke
Sponsor:
Second Affiliated Hospital of Guangxi Medical University
Organization:
Second Affiliated Hospital of Guangxi Medical University
Study Overview
Official Title:
Safety and Efficacy of Evolocumab in in Combination With Statin Therapy in Adults With Ischemic Stroke
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SEEIS
Brief Summary:
The goal of this clinical trial is to evaluate the effect of evolocumab in combination with statin therapy atorvastatin in acute ischemic stroke AIS
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None